Clinical Trials Logo
  1. Home
  2. Venous Malformation
  3. NCT04486599

Electromagnetic Navigation During Ultrasound Guided Foam Sclerotherapy for Venous Malformations — SCLERONAV  

Venous Malformation Clinical Trial

Official title:
Feasibility of Electromagnetic Navigation During Ultrasound Guided Foam Sclerotherapy for the Treatment of Venous Malformations.

Clinical Trial Summary

The aim of this study is to evaluate the feasibility of assisted electromagnetic navigation in percutaneous echo-guided sclerotherapy of slow-flow vascular malformations. Feasibility will be defined in terms of the percentage of patients for whom the procedure is successful.

Clinical Trial Description

Primary interventional treatment of low flow vascular anomalies includes ultrasound guided foam sclerotherapy. Each procedure involves a percutaneous needle insertion. However, procedures remain complicated to obtain the right trajectory in order to inject the foam at the center of the abnormality. Electromagnetic navigation system tracks the operator's needle, meaning the position and progression of the needle is visualized in 3D real time on the ultrasound probe interface. The present trial evaluate the feasibility of the electromagnetic navigation system during the needle insertion and the improvement of needle placement accuracy. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT04486599
Study type Interventional
Source University Hospital, Toulouse
Contact
Status Completed
Phase N/A
Start date July 15, 2020
Completion date May 12, 2022
View Details
See also
  Status Clinical Trial Phase
Terminated NCT04409145 - First in Human Trial of Topical VT30 in Pts With Venous/Lymphatic Malformations Assoc With PIK3CA or TEK Gene Mutations Phase 1/Phase 2
Completed NCT05586919 - Treatment of Venous Malformation N/A
Completed NCT04637997 - Influence of Flat-knitted Compression Stockings Class I and II on Venous Malformations N/A
Recruiting NCT03767660 - Efficacy of Rapamycin (Sirolimus) in the Treatment of BRBNS, Hereditary or Sporadic Venous Malformation Phase 4
Recruiting NCT04861064 - Weekly Sirolimus Therapy Phase 2
Completed NCT04930952 - Complications of Ethanol-amine Oleate Intralesional Sclerotherapy
Recruiting NCT05563831 - National Evaluation of Patients With PIK3CA-Related Overgrowth Spectrum (PROS)
Recruiting NCT04258046 - Trametinib in the Treatment of Complicated Extracranial Arterial Venous Malformation Phase 2
Not yet recruiting NCT05983159 - A Trial of Targeted Therapies for Patients With Slow-Flow or Fast-Flow Vascular Malformations Phase 2
Active, not recruiting NCT01347294 - Compare Two Different Sclerosing Agents in the Treatment of Venous Malformations Phase 4
Completed NCT04836884 - Vascular Anomaly Pathology and Genomics Biopsy Study N/A